These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30648999)

  • 41. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
    Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
    Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
    van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
    Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
    BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
    Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA
    Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
    de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
    Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies for Colorectal Cancer Screening.
    Ladabaum U; Dominitz JA; Kahi C; Schoen RE
    Gastroenterology; 2020 Jan; 158(2):418-432. PubMed ID: 31394083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.
    Shahidi N; Gentile L; Gondara L; Hamm J; McGahan CE; Enns R; Telford J
    Can J Gastroenterol Hepatol; 2016; 2016():4650471. PubMed ID: 28116286
    [No Abstract]   [Full Text] [Related]  

  • 51. Barriers and Facilitators of Colorectal Cancer Screening for Patients of Rural Accountable Care Organization Clinics: A Multilevel Analysis.
    Wang H; Qiu F; Gregg A; Chen B; Kim J; Young L; Wan N; Chen LW
    J Rural Health; 2018 Mar; 34(2):202-212. PubMed ID: 28686787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening colonoscopy use among individuals at higher colorectal cancer risk.
    Longacre AV; Cramer LD; Gross CP
    J Clin Gastroenterol; 2006 Jul; 40(6):490-6. PubMed ID: 16825930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopist Specialty Predicts the Likelihood of Recommending Cessation of Colorectal Cancer Screening in Older Adults.
    Calderwood AH; Anderson JC; Robinson CM; Butterly LF
    Am J Gastroenterol; 2018 Dec; 113(12):1862-1871. PubMed ID: 30390031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.
    Schlichting JA; Mengeling MA; Makki NM; Malhotra A; Halfdanarson TR; Klutts JS; Levy BT; Kaboli PJ; Charlton ME
    J Am Board Fam Med; 2015; 28(4):494-7. PubMed ID: 26152441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.
    Lieberman D; Ladabaum U; Cruz-Correa M; Ginsburg C; Inadomi JM; Kim LS; Giardiello FM; Wender RC
    JAMA; 2016 Nov; 316(20):2135-2145. PubMed ID: 27893135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Travel Time to Colonoscopy Associated With Late-Stage Colorectal Cancer Among Medicare Beneficiaries in Iowa?
    Charlton ME; Matthews KA; Gaglioti A; Bay C; McDowell BD; Ward MM; Levy BT
    J Rural Health; 2016 Sep; 32(4):363-373. PubMed ID: 26610280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.